Respiratory Medicine

Sustained patient use and improved outcomes with digital transformation of a COPD service: RECEIVER trial and DYNAMIC-SCOT COVID-19 scale-up response
A Taylor, A Cushing, M Dow, J Anderson, G McDowell, S Lua, M Manthe, S Padmanabhan, S Burns, P McGinness, DJ Lowe, C Carlin

medRxiv 2022.04.04.22273427; doi: https://doi.org/10.1101/2022.04.04.22273427

Add to Selected Citations
Nonutility of procalcitonin for diagnosing bacterial pneumonia in COVID-19
Avi J. Cohen, Laura R. Glick, Seohyuk Lee, Yukiko Kunitomo, Derek A. Tsang, Sarah Pitafi, Patricia Valda Toro, Ethan Zhang, Rupak Datta, Charles S. Dela Cruz, Samir Gautam

medRxiv 2022.03.29.22272960; doi: https://doi.org/10.1101/2022.03.29.22272960

Add to Selected Citations
A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease
Joshua J. Solomon, Sonye Danoff, Felix Woodhead, Shelley Hurwitz, Rie Maurer, Ian Glaspole, Paul F. Dellaripa, Bibek Gooptu, Robert Vassallo, P. Gerald Cox, Kevin R. Flaherty, Huzaifa I. Adamali, Michael A. Gibbons, Lauren Troy, Ian Forrest, Joseph A. Lasky, Lisa G. Spencer, Jeffrey Golden, Mary Beth Scholand, Nazia Chaudhuri, Mark A. Perella, David Lynch, Daniel C. Chambers, Martin Kolb, Cathie Spino, Ganesh Raghu, Hilary Goldberg, Ivan O. Rosas, the TRAIL1 Network Investigators

medRxiv 2022.04.01.22273270; doi: https://doi.org/10.1101/2022.04.01.22273270

Add to Selected Citations
Using genetic information to define idiopathic pulmonary fibrosis in UK Biobank
Olivia C Leavy, Richard J Allen, Luke M Kraven, Ann Morgan, Martin D Tobin, Jennifer K Quint, R Gisli Jenkins, Louise V Wain

medRxiv 2022.04.01.22273306; doi: https://doi.org/10.1101/2022.04.01.22273306

Add to Selected Citations
Ivacaftor, not ivacaftor/lumacaftor, is associated with lower pulmonary inflammation in preschool cystic fibrosis
Shivanthan Shanthikumar, Sarath Ranganathan, Melanie R. Neeland

medRxiv 2022.03.28.22273066; doi: https://doi.org/10.1101/2022.03.28.22273066

Add to Selected Citations
Genome-wide analysis of longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis
Richard J Allen, Justin M Oldham, David A Jenkins, Olivia C Leavy, Beatriz Guillen-Guio, Carl A Melbourne, Shwu-Fan Ma, Jonathan Jou, John S Kim, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative, William A Fahy, Eunice Oballa, Richard B Hubbard, Vidya Navaratnam, Rebecca Braybrooke, Gauri Saini, Katy M Roach, Martin D Tobin, Nik Hirani, Moira K B Whyte, Naftali Kaminski, Yingze Zhang, Fernando J Martinez, Angela L Linderholm, Ayodeji Adegunsoye, Mary E Strek, Toby M Maher, Philip L Molyneaux, Carlos Flores, Imre Noth, R Gisli Jenkins, Louise V Wain

medRxiv 2022.03.28.22272832; doi: https://doi.org/10.1101/2022.03.28.22272832

Add to Selected Citations
COVID-19 outcomes associated with clinical and demographic characteristics in patients hospitalized with severe and critical disease in Peshawar
Muhammad Imran, Azharuddin, Muhammad Yousaf, Sajjad Khan, Abdul Jalil Khan, Zafar Iqbal, RahmanUllah Jan, Shahid Khan, Muhammad Salman Khan

medRxiv 2022.03.24.22272884; doi: https://doi.org/10.1101/2022.03.24.22272884

Add to Selected Citations
The gut microbiome is a significant risk factor for future chronic lung disease
Yang Liu, Shu Mei Teo, Guillaume Meric, Howard H.F. Tang, Qiyun Zhu, Jon G Sanders, Yoshiki Vazquez-Baeza, Karin Verspoor, Ville A Vartiainen, Pekka Jousilahti, Leo Lahti, Teemu Niiranen, Aki S. Havulinna, Rob Knight, Veikko Salomaa, Michael Inouye

medRxiv 2022.03.22.22272736; doi: https://doi.org/10.1101/2022.03.22.22272736

Add to Selected Citations
Patient-reported respiratory outcome measures in the recovery of adults hospitalised with COVID-19: A systematic review and meta-analysis
Sophie Middleton, Christos Chalitsios, Tricia. M. McKeever, Alex R. Jenkins, Charlotte. E. Bolton

medRxiv 2022.03.16.22272509; doi: https://doi.org/10.1101/2022.03.16.22272509

Add to Selected Citations
Interstitial lung damage following COVID-19 hospitalisation: an interim analysis of the UKILD Post-COVID study
I Stewart, J Jacob, PM George, PL Molyneaux, JC Porter, RJ Allen, JK Baillie, SL Barratt, P Beirne, SM Bianchi, JF Blaikley, J Chalmers, RC Chambers, N Chadhuri, C Coleman, G Collier, EK Denneny, A Docherty, O Elneima, RA Evans, L Fabbri, MA Gibbons, FV Gleeson, B Gooptu, NJ Greening, B Guillen Guio, IP Hall, NA Hanley, V Harris, EM Harrison, M Heightman, TE Hillman, A Horsley, L Houchen-Wolloff, I Jarrold, SR Johnson, MG Jones, F Khan, R Lawson, OC Leavy, N Lone, M Marks, H McAuley, P Mehta, E Omer, D Parekh, K Piper Hanley, M Platé, J Pearl, K Poinasamy, JK Quint, B Raman, M Richardson, P Rivera-Ortega, LC Saunders, R Saunders, MG Semple, M Sereno, A Shikotra, AJ Simpson, A Singapuri, DJF Smith, M Spears, LG Spencer, S Stanel, D Thickett, AAR Thompson, M Thorpe, R Thwaites, SLF Walsh, S Walker, ND Weatherley, M Weeks, JM Wild, DG Wootton, CE Brightling, LP Ho, LV Wain, RG Jenkins

medRxiv 2022.03.10.22272081; doi: https://doi.org/10.1101/2022.03.10.22272081

Add to Selected Citations

Respiratory Medicine

Pages